Ontario will be pausing the rollout and administration of first doses of the AstraZeneca-Oxford COVID-19 vaccine, effective Tuesday, due to concerns over rare but potentially fatal blood clots.
Ontario will be pausing the rollout and administration of first doses of the AstraZeneca-Oxford COVID-19 vaccine, effective Tuesday, due to concerns over rare but potentially fatal blood clots.